XTX Topco’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
+17,467
New +$1.14M 0.02% 1217
2025
Q3
Sell
-35,331
Closed -$1.3M 3303
2025
Q2
$1.3M Buy
35,331
+20,187
+133% +$697K 0.05% 519
2025
Q1
$595K Sell
15,144
-20,302
-57% -$914K 0.03% 901
2024
Q4
$1.65M Buy
35,446
+19,928
+128% +$901K 0.14% 125
2024
Q3
$701K Buy
15,518
+4,169
+37% +$198K 0.05% 598
2024
Q2
$559K Buy
11,349
+3,851
+51% +$157K 0.05% 603
2024
Q1
$257K Buy
7,498
+828
+12% +$29.9K 0.03% 975
2023
Q4
$246K Sell
6,670
-20,036
-75% -$463K 0.05% 793
2023
Q3
$541K Sell
26,706
-2,916
-10% -$64.1K 0.09% 353
2023
Q2
$606K Buy
+29,622
New +$444K 0.11% 262

Other funds holding TWST

XTX Topco's TWST Position: Q2 2026 in Review

XTX Topco opened a new position in Twist Bioscience (TWST) in Q2 2026: 17,467 shares worth $1.8M. The stake represents 0.02% of the portfolio and ranks #1217 among its holdings. This is a return to the name: XTX Topco previously reported a position in TWST as recently as Q2 2025.

XTX Topco first reported a position in TWST in Q2 2023 and has held it in 10 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • XTX Topco held 17,467 shares of Twist Bioscience worth $1.8M as of Q2 2026.
  • Twist Bioscience was a new XTX Topco position in Q2 2026.
  • Twist Bioscience made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1217 holding.
  • XTX Topco first reported a position in Twist Bioscience in Q2 2023 and has held it in 10 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.